|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Akari Therapeutics (NASDAQ: AKTX) through any online brokerage.
The latest price target for Akari Therapeutics (NASDAQ: AKTX) was reported by B. Riley FBR on 2020-03-13. The analyst firm set a price target for 5.00 expecting AKTX to rise to within 12 months (a possible 176.24% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Akari Therapeutics (NASDAQ: AKTX) is $1.81 last updated Fri May 07 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Akari Therapeutics.
There is no upcoming split for Akari Therapeutics.